Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision.
The set of guidelines for good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents, which was developed following an international consensus conference in Copenhagen, has been revised and updated following the second consensus conference in Stockholm in 2005. It is hoped that these guidelines will continue to help researchers in the field and assist the pharmaceutical industry and equipment manufacturers in enhancing the standards of the studies they sponsor.
Fuchs-Buder
T
T
Department of Anaesthesiology and Intensive Care Medicine, University of Nancy, France. t.fuchs-buder@chu-nancy.fr
Claudius
C
C
Skovgaard
L T
LT
Eriksson
L I
LI
Mirakhur
R K
RK
Viby-Mogensen
J
J
D000758:Anesthesia; D002986:Clinical Trials as Topic / Q000592:standards* / Q000706:statistics & numerical data; D004305:Dose-Response Relationship, Drug; D007442:Intubation, Intratracheal; D016343:Monitoring, Intraoperative; D009213:Myography; D009407:Nerve Block; D009466:Neuromuscular Blocking Agents / Q000494:pharmacology*; D012107:Research Design; D013548:Sweden
D009466:Neuromuscular Blocking Agents